Popular Articles

New Centre In London To Accelerate Personalized Mental Health Care
A powerful new research facility at the heart of King"s Health Partners Academic Health Sciences Centre has been launched by Professor Dame Sally C Davies, Director General of Research and Development and Chief Scientific Adviser, Department of Health. The Biomedical Research Centre (BRC) Nucleus is funded by a ÷£3M infrastructure grant from South London and Maudsley Charitable Funds (÷£1.8M) and Guy"s and St Thomas" Charity (÷£1.2M) to create a unique centre housing key translational initiatives to support the development of novel therapies and treatments for mental health and related disorders.
drugs without prescription
WHO Approves Second HPV Vaccine
The WHO announced Thursday it had approved a second cervical cancer vaccine, opening "U.N. agencies and partners [to] now officially buy millions of doses of the vaccine for poor countries worldwide," where an estimated 80 percent of the 280,000 annual deaths from cervical cancer occur each year, the AP/Google.com reports (7/9).
News of the day
Device Uses Human Liver Cells To Assist Organ's Functions
The first artificial organ for liver patients that uses immortalized human liver cells, the Extracorporeal Liver Assist Device, or ELAD®, is a bedside system that treats blood plasma, metabolizing toxins and synthesizing proteins just like a real liver does.
Oncology

Accouncing The Leading European Congress On Cardiac Arrhythmias And Pacing: EUROPACE 2009

EUROPACE, the official congress of the European Heart Rhythm Association (EHRA), is the foremost European meeting on cardiac arrhythmias and pacing. More than 4,000 participants are expected to attend this year"s event, whose main themes are atrial fibrillation and sudden cardiac death. EHRA is a registered branch of the European Society of Cardiology (ESC). Its mission is to reduce the impact of cardiac arrhythmias and sudden cardiac death (SCD). EUROPACE 2009 will be held from 21-24 June in ICC Berlin, Germany. The press conference in Berlin will highlight several themes from the EUROPACE 2009 scientific programme: * How to improve the quality of care with a more uniform treatment of arrhythmias and better prevention of sudden cardiac death in all European countries. * Cardiac arrhythmias in athletes will be another important topic. A scientific session will consider the requirement for screening of all athletes to avoid sudden cardiac death and the implications of an abnormal electrocardiogram (ECG) in an athlete. The prevalence of cardiac arrhythmias in the athlete"s heart will be debated. * Hot Line sessions will be a major feature at EUROPACE 2009 (Tuesday 23 June). Devoted to late-breaking news from clinical trials, the ESC"s Hot Line sessions are renowned for making strong stories in medical news and will be discussed at the press conference. Also presented at the press conference: * Remote monitoring * Latest facts and figures on arrhythmias in Europe * Driving with ICD * Beat-It! Campaign Notes: 1. Sudden cardiac death claims more lives than stroke, lung cancer, breast cancer and AIDS combined. Incidence is less than 1% per year in the general population, but rising to more than 30% in high-risk post-MI subgroups. 2. Cardiac arrhythmia describes conditions in which heart beat is too fast, too slow, or irregular. The cause is abnormal electrical activity in the heart. Some arrhythmias may be life-threatening and result in sudden cardiac death. The average healthy heart beats 200,000 times per day. 3. The most common arrhythmia (after a skipped beat) is atrial fibrillation, which affects up to 5 per cent of all adults, mainly the over-65s. * Information on the scientific programme for Europace 2009 is available at http://spo.escardio.org/Welcome.aspx?eevtid=32 ESC Press Office European Society of Cardiology


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):